Comac Medical is thrilled to announce our participation in the BIO International Convention 2025, taking place from June 16 to 19 at the Boston Convention & Exhibition Center. This premier event stands as the largest and most comprehensive gathering in the biotechnology sector, bringing together over 20,000 industry leaders from more than 70 countries.

Representing Comac Medical at this global summit are Senior Business Development Directors, Chris Lancaster and Kelly Conti, and Business Development Director, Thomas Dent. Our team is eager to engage with fellow professionals, share insights, and explore collaborative opportunities that drive innovation in clinical research.

The convention’s agenda is rich with over 135 sessions covering 18 focus areas, including AI and digital health, next-generation biotherapeutics, and business development strategies. A highlight of the event is the BIO One-on-One Partnering system, which facilitates meaningful connections through scheduled meetings, fostering partnerships that propel the industry forward.

We invite you to get in touch with our attendees to learn more about Comac Medical’s expanding global presence and how we can support your clinical trial needs. Let’s connect in Boston and shape the future of biotechnology together.